- 11501. better
- [Better (of severity or nominal observations) ( HL7V3.0 )] (UMLS (HL7) C1550462) =Idea or Concept =ObservationInterpretationChange;
| - 11551. Bevacizumab/Paclitaxel
- (UMLS (NCI) C1134547) =Therapeutic or Preventive Procedure
|
- 11502. Better eye: moderate vision impairment; lesser eye: blind, not further specified
- [ ] (UMLS (ICD9CM) C0392566) =Disease or Syndrome
| - 11552. Bevacizumab/PEG-Interferon Alfa-2b
- (UMLS (NCI) C1327908) =Therapeutic or Preventive Procedure ;
|
- 11503. Better eye: moderate vision impairment; lesser eye: impairment not further specified
- [ ] (UMLS (ICD9CM) C0392571) =Disease or Syndrome
| - 11553. Bevacizumab/Thalidomide
- (UMLS (NCI) C0935722) =Therapeutic or Preventive Procedure
|
- 11504. Better eye: moderate vision impairment; lesser eye: moderate vision impairment
- [ ] (UMLS (ICD9CM) C0271239) =Disease or Syndrome
| - 11554. Bevacizumab/Vinorelbine
- (UMLS (NCI) C0935867) =Therapeutic or Preventive Procedure ;
|
- 11505. Better eye: moderate vision impairment; lesser eye: near-total vision impairment
- [ ] (UMLS (ICD9CM) C0392568) =Disease or Syndrome
| - 11555. beverage
- [liquids suitable for drinking. ( CSP )] (UMLS (CSP) C0005329) =Food
|
- 11506. Better eye: moderate vision impairment; lesser eye: profound vision impairment
- [ ] (UMLS (ICD9CM) C0392569) =Disease or Syndrome
| - 11556. Bexarotene/Carboplatin/Paclitaxel
- (UMLS (NCI) C1134643) =Therapeutic or Preventive Procedure
|
- 11507. Better eye: moderate vision impairment; lesser eye: severe vision impairment
- [ ] (UMLS (ICD9CM) C0392572) =Disease or Syndrome
| - 11557. Bexarotene/Cisplatin/Vinorelbine
- (UMLS (NCI) C1134565) =Therapeutic or Preventive Procedure
|
- 11508. Better eye: moderate vision impairment; lesser eye: total vision impairment
- [ ] (UMLS (ICD9CM) C0392567) =Disease or Syndrome
| - 11558. Bexarotene/Interferon Alfa
- (UMLS (NCI) C0338343) =Therapeutic or Preventive Procedure ;
|
- 11509. Better eye: near-total vision impairment; lesser eye: near-total vision impairment
- [ ] (UMLS (ICD9CM) C0271220) =Disease or Syndrome ;
| - 11559. Bexxar
- (UMLS (NCI) C0919272) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
- 11510. Better eye: near-total vision impairment; lesser eye: not further specified
- [ ] (UMLS (ICD9CM) C0521709) =Disease or Syndrome ;
| - 11560. BF
- [A country in Western Africa, north of Ghana. (NCI) ( NCI )] (UMLS (NCI) C0006409) =Geographic Area ;
|
- 11511. Better eye: near-total vision impairment; lesser eye: total vision impairment
- [ ] (UMLS (ICD9CM) C0392558) =Disease or Syndrome ;
| - 11561. BF1 Protein
- [Forkhead Box Protein G1B acts as transcriptional repressor and belongs to the large FKH/HNF3 family of transcription factors, that includes the Drosophila homeotic FKH and mammalian HNF3 and BF1 proteins. Family members share a unique DNA-binding FKH box. FOXG1B expression is restricted to telencephalic neurons, with strong expression in the dentate gyrus and hippocampus. (from OMIM 164874 and NCI) ( NCI )] (UMLS (NCI) C0290266) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 11512. Better eye: profound vision impairment; lesser eye: near-total vision impairment
- [ ] (UMLS (ICD9CM) C0392561) =Disease or Syndrome ;
| - 11562. BG
- [A country in Southeastern Europe, bordering the Black Sea, between Romania and Turkey. (NCI) ( NCI )] (UMLS (NCI) C0006368) =Geographic Area ;
|
- 11513. Better eye: profound vision impairment; lesser eye: not further specified
- [ ] (UMLS (ICD9CM) C0392559) =Disease or Syndrome ;
| - 11563. BG00001
- (UMLS (NCI) C1134622) =Pharmacologic Substance ;
|
- 11514. Better eye: profound vision impairment; lesser eye: profound vision impairment
- [ ] (UMLS (ICD9CM) C0271224) =Disease or Syndrome ;
| - 11564. BH3 Interacting Domain Death Agonist
- [BID (BH3 Interacting domain Death agonist) is a death agonist that heterodimerizes with either agonists (BAX) or antagonists (BCL2). BID is a member of the BCL-2 family of cell death regulators. BID is a mediator of mitochondrial damage induced by caspase-8 (CASP8); CASP8 cleaves BID, and the COOH-terminal part translocates to mitochondria where it triggers cytochrome c release. (from RefSeq Summary) ( NCI )] (UMLS (NCI) C0531588) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 11515. Better eye: profound vision impairment; lesser eye: total vision impairment
- [ ] (UMLS (ICD9CM) C0392560) =Disease or Syndrome ;
| - 11565. BH3 Interacting Domain Death Agonist Gene
- [This gene is involved in the regulation of apoptosis. ( NCI )] (UMLS (NCI) C1332410) BID;
BID Gene;
=Gene or Genome ;
|
- 11516. Better eye: severe vision impairment; lesser eye: near-total vision impairment
- [ ] (UMLS (ICD9CM) C0392564) =Disease or Syndrome
| - 11566. BHUTAN
- [A country in Southern Asia, between China and India. (NCI) ( NCI )] (UMLS (NCI) C0005341) =Geographic Area
|
- 11517. Better eye: severe vision impairment; lesser eye: profound vision impairment
- [ ] (UMLS (ICD9CM) C0392565) =Disease or Syndrome
| - 11567. Bhutanese
- [Denotes the inhabitants of Bhutan, a person from there, or their descendants elsewhere. ( NCI )] (UMLS (NCI) C0337894) =Population Group ;
=Asian;
|
- 11518. Better eye: severe vision impairment; lesser eye: severe vision impairment
- [ ] (UMLS (ICD9CM) C0271236) =Disease or Syndrome
| - 11568. Bi element
- [metallic element with atomic symbol Bi, atomic number 83 and atomic weight 208.98; its salts have astringent, antacid and mildly germicidal properties. ( CSP )] (UMLS (CSP) C0005642) =Element, Ion, or Isotope ;
|
- 11519. Better eye: severe vision impairment; lesser eye: total vision impairment
- [ ] (UMLS (ICD9CM) C0392563) =Disease or Syndrome
| - 11569. Bi-Cytopenia
- (UMLS (NCI) C1332547) =Finding
|
- 11520. Better eye: severe vision impairment; lesser eye; impairment not further specified
- [ ] (UMLS (ICD9CM) C0392570) =Disease or Syndrome
| - 11570. Biafine
- (UMLS (NCI) C0677828) =Lipid; Pharmacologic Substance
|
- 11521. Better eye: total vision impairment; lesser eye: total vision impairment
- [ ] (UMLS (ICD9CM) C0155022) =Disease or Syndrome
| - 11571. Biafine Cream
- [A topical preparation to reduce the risk of, and treat skin reactions to, radiation therapy. ( NCI )] (UMLS (NCI) C1331090) =Clinical Drug
|
- 11522. Better--use when direction not relevant
- (UMLS (HL7) C0694716) =Laboratory or Test Result ;
=Abnormal flags;
| - 11572. Biantrazole
- (UMLS (NCI) C0969814) =Organic Chemical; Pharmacologic Substance ;
|
- 11523. between breakfast and lunch
- (UMLS (HL7) C1549045) =Temporal Concept =Event related period;
| - 11573. bias
- [In a clinical trial, a flaw in the study design or method of collecting or interpreting information. Biases can lead to incorrect conclusions about what the study or trial showed. ( NCI )] (UMLS (NCI) C0242568) =Idea or Concept ;
=attitude;
|
- 11524. between dinner and the hour of sleep
- (UMLS (HL7) C1549046) =Temporal Concept =Event related period;
| - 11574. Biaxin
- (UMLS (NCI) C0701281) =Organic Chemical; Antibiotic ;
|
- 11525. between lunch and dinner
- (UMLS (HL7) C1549044) =Temporal Concept =Event related period;
| - 11575. BIBR 277
- (UMLS (NCI) C0740241) =Organic Chemical; Pharmacologic Substance
|
- 11526. Between Meals
- [In between meals. ( NCI )] (UMLS (NCI) C0587121) =Temporal Concept ;
| - 11576. BIBX 1382
- [A drug that may inhibit tumor cells from multiplying. It is being studied for its ability to treat cancer. ( NCI )] (UMLS (NCI) C0879286) BIBX1382;
=Organic Chemical; Pharmacologic Substance ;
|
- 11527. between meals (from lat. inter cibus)
- (UMLS (HL7) C1549043) =Temporal Concept =Event related period;
| - 11577. Bicalutamide/Buserelin
- (UMLS (NCI) C0677836) =Therapeutic or Preventive Procedure ;
|
- 11528. Beuren syndrome
- [syndrome of elfinlike facies, mental retardation, growth deficiency, cardiovascular anomalies, and idiopathic infantile hypercalcemia. ( CSP )] (UMLS (CSP) C0175702) =Disease or Syndrome ;
=Aortic Stenosis, Supravalvular;
Chromosomal anomalies;
syndrome;
congenital disorder;
Chromosomal Disorders, Nervous System;
| - 11578. Bicalutamide/Exemestane
- (UMLS (NCI) C1134586) =Therapeutic or Preventive Procedure ;
|
- 11529. Bevacizumab/Capecitabine
- (UMLS (NCI) C0935797) =Therapeutic or Preventive Procedure
| - 11579. Bicalutamide/Goserelin
- (UMLS (NCI) C0281353) =Therapeutic or Preventive Procedure
|
- 11530. Bevacizumab/Capecitabine/Oxaliplatin
- (UMLS (NCI) C1328044) =Therapeutic or Preventive Procedure ;
| - 11580. Bicalutamide/Goserelin/Mitoxantrone/Prednisone
- (UMLS (NCI) C0879354) =Therapeutic or Preventive Procedure ;
|
- 11531. Bevacizumab/Carboplatin/Paclitaxel
- (UMLS (NCI) C0935884) =Therapeutic or Preventive Procedure
| - 11581. Bicalutamide/Leuprolide
- (UMLS (NCI) C0281352) =Therapeutic or Preventive Procedure
|
- 11532. Bevacizumab/Cetuximab
- (UMLS (NCI) C1328136) =Therapeutic or Preventive Procedure ;
| - 11582. Bicalutamide/Triptorelin
- (UMLS (NCI) C1327902) =Therapeutic or Preventive Procedure ;
|
- 11533. Bevacizumab/Cetuximab/Irinotecan
- (UMLS (NCI) C1328137) =Therapeutic or Preventive Procedure ;
| - 11583. Biceps
- (UMLS (NCI) C0559499) =Body Part, Organ, or Organ Component
|
- 11534. Bevacizumab/Cisplatin/Gemcitabine
- (UMLS (NCI) C1134521) =Therapeutic or Preventive Procedure
| - 11584. Biceps Femoris
- (UMLS (NCI) C0224449) =Body Part, Organ, or Organ Component
|
- 11535. Bevacizumab/Cyclophosphamide
- (UMLS (NCI) C1328090) =Therapeutic or Preventive Procedure; ;
| - 11585. BICEPS TENDON RUPTURE
- (UMLS (ICD9CM) C0158342) =Disease or Syndrome
|
- 11536. Bevacizumab/Cytarabine/Idarubicin
- (UMLS (NCI) C1134480) =Therapeutic or Preventive Procedure
| - 11586. Bichon Frise
- [The Bichon Frise has a loosely curled double coat consisting of a textured outer coat lined with a soft, fine, silky undercoat that is virtually hypo-allergenic. It is usually all white. Height: 9-12 inches (23-30 cm.) Weight: 7-12 pounds (3-5 kg.) ( NCI )] (UMLS (NCI) C0324314) =Mammal
|
- 11537. Bevacizumab/Docetaxel
- (UMLS (NCI) C1134527) =Therapeutic or Preventive Procedure
| - 11587. Bicillin
- (UMLS (NCI) C0729074) =Organic Chemical; Antibiotic ;
|
- 11538. Bevacizumab/Docetaxel/Doxorubicin
- (UMLS (NCI) C0935900) =Therapeutic or Preventive Procedure
| - 11588. BICIPITAL TENOSYNOVITIS
- [ ] (UMLS (ICD9CM) C0158304) =Disease or Syndrome ;
|
- 11539. Bevacizumab/Docetaxel/Estramustine
- (UMLS (NCI) C0935852) =Therapeutic or Preventive Procedure
| - 11589. BiCNU
- (UMLS (NCI) C1145713) =Organic Chemical; Pharmacologic Substance
|
- 11540. Bevacizumab/Doxorubicin
- (UMLS (NCI) C1327827) =Therapeutic or Preventive Procedure ;
| - 11590. bicuculline
- [plant alkaloid with GABA antagonist properties, used as a probe for GABA function in the nervous system. ( CSP )] (UMLS (CSP) C0005372) =Organic Chemical; Pharmacologic Substance ;
|
- 11541. Bevacizumab/Erlotinib
- (UMLS (NCI) C1327881) =Therapeutic or Preventive Procedure ;
| - 11591. BICYCLE ERGOMETER TEST
- (UMLS (ICD9CM) C0430459) =Diagnostic Procedure
|
- 11542. Bevacizumab/Fluorouracil
- (UMLS (NCI) C1327837) =Therapeutic or Preventive Procedure; ;
| - 11592. bicyclic compound
- [chemical compound containing two ring structures. ( CSP )] (UMLS (CSP) C0005378) =Organic Chemical
|
- 11543. Bevacizumab/Fluorouracil/Hydroxyurea
- (UMLS (NCI) C1134475) =Therapeutic or Preventive Procedure
| - 11593. BID
- [Two times per day, at unspecified times. ( NCI )] (UMLS (NCI) C0585361) =Temporal Concept =GTSAbbreviation;
|
- 11544. Bevacizumab/Fluorouracil/Irinotecan/Leucovorin Calcium
- (UMLS (NCI) C0935737) =Therapeutic or Preventive Procedure
| - 11594. Bielschowsky stain
- [Stain, Bielschowsky ( HL7V3.0 )] (UMLS (HL7) C1293957) Bielschowsky's silver stain;
=Laboratory Procedure =ObservationMethod;
|
- 11545. Bevacizumab/Fluorouracil/Leucovorin Calcium
- (UMLS (NCI) C0935792) =Therapeutic or Preventive Procedure
| - 11595. Big Alpha
- [List is ordered using big alpha characters: A, B, C ( HL7V3.0 )] (UMLS (HL7) C1552592) =Intellectual Product =Ordered List Style;
|
- 11546. Bevacizumab/Fluorouracil/Leucovorin Calcium/Oxaliplatin
- (UMLS (NCI) C1134498) =Therapeutic or Preventive Procedure
| - 11596. Big Lagoon Rancheria, California
- (UMLS (HL7) C1554234) =Population Group =NativeEntityContiguous;
|
- 11547. Bevacizumab/Gemcitabine
- (UMLS (NCI) C1134551) =Therapeutic or Preventive Procedure ;
| - 11597. Big Pine Band of Owens Valley Paiute Shoshone Indi
- (UMLS (HL7) C1554235) =Population Group =NativeEntityContiguous;
|
- 11548. Bevacizumab/Imatinib Mesylate
- (UMLS (NCI) C1328110) =Therapeutic or Preventive Procedure; ;
| - 11598. Big Roman
- [List is ordered using big Roman numerals: I, II, III ( HL7V3.0 )] (UMLS (HL7) C1552590) =Intellectual Product =Ordered List Style;
|
- 11549. Bevacizumab/Interferon Alfa
- (UMLS (NCI) C1134504) =Therapeutic or Preventive Procedure
| - 11599. Big Sandy Rancheria of Mono Indians of California
- (UMLS (HL7) C1554236) =Population Group =NativeEntityContiguous;
|
- 11550. Bevacizumab/Irinotecan
- (UMLS (NCI) C0935793) =Therapeutic or Preventive Procedure
| - 11600. Big Valley Band of Pomo Indians of the Big Valley
- (UMLS (HL7) C1554237) =Population Group =NativeEntityContiguous;
|
home 
Armenian-English 
top